Research and Development

Showing 15 posts of 9612 posts found.

Working through the ‘ZOUD’

July 7, 2011 Business Services, Research and Development, Sales and Marketing careers, management, recruitment

Most senior managers find their executive team difficult. ‘Dysfunctional’ is a favourite word. Testing dynamics, political agendas, big personalities, strong …

BMS licences potential first-in-class cancer biologic

July 7, 2011 Research and Development BMS, Cancer, biologics

Bristol-Myers Squibb has signed a $465 million deal for the rights to a potential first-in-class treatment for cancer. IPH2102 is …

Former Sanofi-Pasteur MSD president joins board at Genticel

July 6, 2011 Research and Development appointment, research and development

Genticel has named Dr Didier Hoch, former president of Sanofi-Pasteur MSD, to its supervisory board as conseil de surveillance.Dr Hoch …
Sanofi

Sanofi to research new types of antibiotics

July 6, 2011 Research and Development Antibiotics, Rib-X Pharmaceuticals, Sanofi, research and development news

Sanofi has signed a research collaboration with Rib-X Pharmaceuticals to investigate new types of antibiotics. The French pharma company has …

Contract research news in brief

July 6, 2011 Research and Development CIToxLAB, Jubilant, PupPharma, Quintiles, Toxikon, research and development news

Quintiles helps fund Alzheimer’s drug programme, Toxikon starts building a new facility, plus updates from Jubilant, CIToxLAB and PupPharma. Quintiles …
Pfizer

Study claims cardiovascular risk to Pfizer’s Champix

July 6, 2011 Research and Development, Sales and Marketing Champix, Chantix, Pfizer, smoking cessation

Pfizer has been drawn into a war of words over its smoking cessation drug Champix after a review of existing …
Merck & Co

Merck to close one facility, boosts another

July 5, 2011 Manufacturing and Production, Research and Development Ireland, Merck & Co, pharma job cuts, pharma manufacturing news

Merck & Co continues to shake up its network of facilities, deciding to close a recently-acquired site in the USA …
Novartis Afinitor (everolimus)

Afinitor stops tumour growth in advanced breast cancer

July 5, 2011 Manufacturing and Production, Research and Development Afinitor, Novartis, Votubia, advanced breast cancer

Novartis’ Afinitor has impressed in a late-stage trial by increasing survival in women with advanced breast cancer. The phase III …

SCM Pharma appoints Adam Sims

July 5, 2011 Manufacturing and Production, Research and Development appointment, manufacturing and production, research and development

Sterile filling specialist SCM Pharma has bolstered its senior management team with the appointment of Adams Sims as a non-executive …

EMA publishes details of new pharmacovigilance format

July 4, 2011 Research and Development, Sales and Marketing EMA, pharmacovigilance

Pharma companies have been given the highly-specific electronic formats in which they will soon have to submit information on medicines …
Eli Lilly & Company

Lilly prepares late-stage pipeline boost

July 1, 2011 Research and Development, Sales and Marketing autoimmune diseases, diabetes, lilly, neuroscience, oncology

Eli Lilly has highlighted diabetes, oncology, autoimmune diseases and neuroscience as key therapy areas within its growth strategy. Within these …

Almirall appoints new general manager for Germany

July 1, 2011 Research and Development, Sales and Marketing Almirall, appointment, research and development, sales and marketing

Spanish pharma company Almirall has promoted Farid Taha to be its general manager for Germany. He joined Almirall in 2000 …

AstraZeneca signs cancer drug discovery collaboration

June 30, 2011 Research and Development AstraZeneca, PTC Therapeutics

AstraZeneca has signed a deal with PTC Therapeutics to use the company’s proprietary drug discovery platform to discover new cancer …

The growing role of regulatory affairs

June 30, 2011 Business Services, Research and Development, Sales and Marketing regulatory affairs, topra

Some years ago, regulatory affairs (RA) was seen by some as merely a ‘front office’ function, providing a necessary interface …
GlaxoSmithKline

GSK welcomes outside researchers to its ‘open lab’

June 29, 2011 Research and Development GSK, TB, academic alliance, malaria, open lab

The first scientists from outside GlaxoSmithKline have started work at the manufacturer’s ‘open lab’ for diseases of the developing world …
The Gateway to Local Adoption Series

Latest content